Purdue OxyContin Abuse-Resistant Pill Will Need 4-5 Years To Complete Trials

Purdue expects clinical trials of abuse-resistant OxyContin formulated with the opioid antagonist naltrexone will take four to five years to complete, after determining that a combination product with naloxone will likely not be feasible